By genetically modifying bacteria, a new startup from the University of Basel known T3 Pharmaceuticals AG want to develop new cancer therapies. Scientists actually took inspiration from nature and they are adapting it to find alternatives to chemotherapy.
Scientists are consolidating two understood regular wonders: that microbes can colonize tumours, and those specific microscopic organisms can infuse independent protein atoms into human cells. To do this, they utilize an ultra-fine needle known as a “type III secretion system”.
The real plan is to reprogram the bacteria in order to transform the desired proteins into the tumour cells. Through this approach, scientists make it possible to introduce therapeutically effective proteins directly into the cancerous cells.
Read more: http://bit.ly/2GscNoC